Baupost Group Buys Over 16 Mln Shares of Idenix Pharmaceuticals Inc (IDIX)

Baupost Group, a fund managed by Seth Klarman, is a large shareholder of Idenix Pharmaceuticals Inc (NASDAQ:IDIX). The fund disclosed, in a new filing with the Securities and Exchange Commission, revealed that it holds 53.33 million shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), equivalent to 35.38% of the common stock.

At the end of January, Idenix Pharmaceuticals Inc (NASDAQ:IDIX)  entered into a subscription agreement with certain entities managed by The Baupost Group, L.L.C. The agreement related to the issuance and sale of an aggregate of 16.42 million shares of the company’s common stock at $6.50 per share. Thereafter, Baupost Group is entitled to 35% of the company’s common stock upon completion of the offering closed on January 31. Earlier, the fund had raised its stake to 36.91 million shares from 26.8 million.

BAUPOST GROUP

The company received $106.7 million of net proceeds from the offering and will use the offering for  general corporate purposes, including clinical trial costs and ongoing and future patent litigation expenses.

Baupost has also been granted observer rights, with respect to meetings of the board of directors of the company and the committees of the company’s board of directors. Baupost Group, acquired the common stock to invest in the ordinary course of business.

Of all the hedge funds we track, Bain Capital’s Brookside Capital is another hedge fund which stands on the second spot, amassing 12.66 million shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), at the end of the third quarter of 2013. 12 West Capital Management, led by Joel Ramin, initiated a stake in the company in the third quarter, and holds 1.78 million shares.

Baupost Group is the 11th largest hedge fund in the world.

Last month, Seth Klarman trimmed his stake in Enzon Pharmaceuticals Inc (NASDAQ:ENZN) to 4.34 million shares from over 7.69 million shares. On the same day the fund revealed in a separate filing that it initiated a stake in Kindred Biosciences Inc (NASDAQ:KIN) and owns 2.9 million shares of the company.

Disclosure: none

Recommended Reading:

Ra Capital Management Initiates Stake in Furiex Pharmaceuticals Inc (FURX) After the Stock Jumped

Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

Deerfield Management & Brookside Capital Revealed Significant Stakes in Newly Public Dicerna Pharmaceuticals Inc (DRNA)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!